StockNews.AI
NAGE
StockNews.AI
134 days

Niagen Bioscience Confirms Its Operations Remain Resilient Amid New Tariff Developments

1. NAGE's manufacturing remains resilient despite new global tariffs. 2. The company maintains focus on healthy aging products.

2m saved
Insight
Article

FAQ

Why Bullish?

NAGE's ability to withstand tariffs may attract investor confidence, similar to previous resilient performances. A strong production capability suggests stability amidst market fluctuations.

How important is it?

The article highlights strength against tariffs, crucial for investor sentiment and stock stability.

Why Short Term?

Positive sentiment likely to boost NAGE's stock immediately following tariff announcement, similar to past reactions in the bioscience sector.

Related Companies

CHRONADGRAC
LOS ANGELES--(BUSINESS WIRE)---- $NAGE #Bioscience--Niagen Bioscience, Inc. (NASDAQ: NAGE) (formerly ChromaDex Corp.), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, reaffirms that the manufacturing of its Niagen® ingredient (patented nicotinamide riboside or NR) and Tru Niagen® and pharmaceutical-grade Niagen® products remain resilient amid the recently enacted global tariffs. Manufactured in the U.S. by the Company's partner, W.R. Grace, Niagen is rig.

Related News